Invesco DWA Healthcare Momentum ETF (PTH) Holdings
PTH holdings summary
as of Oct 25, 2026- Holdings
- 53 positions listed
- Top 10 weight
- 36.4% of net assets
- Effective holdings
- 41 equal-weight equivalent
- Largest holding
- IOVA 5.08% Iovance Biotherapeutics, Inc.
- Annual turnover
- 0.0% of the portfolio traded
All PTH holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 5.08% | $14.5M | $6.17B | — |
| 2 | ROIV | Roivant Sciences Ltd. | Healthcare | 3.95% | $11.3M | $24.22B | — |
| 3 | NTRA | Natera, Inc. | Healthcare | 3.94% | $11.2M | $56.71B | — |
| 4 | THC | Tenet Healthcare Corporation | Healthcare | 3.75% | $10.7M | $21.52B | 10.5 |
| 5 | GH | Guardant Health, Inc. | Healthcare | 3.68% | $10.5M | $21.28B | — |
| 6 | TXG | 10x Genomics, Inc. | Healthcare | 3.62% | $10.3M | $9.10B | — |
| 7 | RVMD | Revolution Medicines, Inc. | Healthcare | 3.50% | $10.0M | $38.14B | — |
| 8 | MEDP | Medpace Holdings, Inc. | Healthcare | 3.06% | $8.7M | $17.26B | 36.3 |
| 9 | INSM | Insmed Incorporated | Healthcare | 2.94% | $8.4M | $21.02B | — |
| 10 | HNGE | Hinge Health, Inc. | Healthcare | 2.90% | $8.3M | $8.00B | 32.7 |
| 11 | TWST | Twist Bioscience Corporation | Healthcare | 2.84% | $8.1M | $8.80B | — |
| 12 | EXEL | Exelixis, Inc. | Healthcare | 2.66% | $7.6M | $15.42B | 19.6 |
| 13 | HALO | Halozyme Therapeutics, Inc. | Healthcare | 2.63% | $7.5M | $13.83B | 35.6 |
| 14 | ILMN | Illumina, Inc. | Healthcare | 2.51% | $7.2M | $39.64B | 49.0 |
| 15 | CRL | Charles River Laboratories International, Inc. | Healthcare | 2.45% | $7.0M | $14.46B | — |
| 16 | PTGX | Protagonist Therapeutics, Inc. | Healthcare | 2.38% | $6.8M | $8.33B | 125.0 |
| 17 | RLAY | Relay Therapeutics, Inc. | Healthcare | 2.31% | $6.6M | $3.57B | — |
| 18 | PACS | PACS Group, Inc. | Healthcare | 2.29% | $6.5M | $7.43B | 27.4 |
| 19 | CDNA | CareDx, Inc | Healthcare | 2.20% | $6.3M | $3.31B | 30.8 |
| 20 | TVTX | Travere Therapeutics, Inc. | Healthcare | 2.06% | $5.9M | $4.61B | — |
| 21 | AXGN | AxoGen, Inc. | Healthcare | 2.03% | $5.8M | $2.03B | — |
| 22 | OSCR | Oscar Health, Inc. | Healthcare | 1.97% | $5.6M | $9.84B | 24.7 |
| 23 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 1.75% | $5.0M | $4.03B | — |
| 24 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 1.72% | $4.9M | $8.62B | — |
| 25 | MBX | MBX Biosciences, Inc. | Healthcare | 1.64% | $4.7M | $2.39B | — |
| 26 | AVAH | Aveanna Healthcare Holdings Inc. | Healthcare | 1.60% | $4.6M | $2.69B | 9.8 |
| 27 | HTFL | Heartflow, Inc. | Healthcare | 1.46% | $4.2M | $4.20B | — |
| 28 | LFST | LifeStance Health Group, Inc. | Healthcare | 1.42% | $4.1M | $4.46B | 90.3 |
| 29 | ATRC | AtriCure, Inc. | Healthcare | 1.41% | $4.0M | $2.85B | 267.0 |
| 30 | CGON | CG Oncology, Inc. | Healthcare | 1.41% | $4.0M | $5.31B | — |
| 31 | NRIX | Nurix Therapeutics, Inc. | Healthcare | 1.41% | $4.0M | $2.67B | 10.0 |
| 32 | AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | 1.38% | $4.0M | $6.68B | 39.1 |
| 33 | EWTX | Edgewise Therapeutics, Inc. | Healthcare | 1.29% | $3.7M | $4.04B | — |
| 34 | NEO | NeoGenomics, Inc. | Healthcare | 1.25% | $3.6M | $2.14B | — |
| 35 | MD | Pediatrix Medical Group, Inc. | Healthcare | 1.24% | $3.6M | $2.22B | 13.1 |
| 36 | PLSE | Pulse Biosciences, Inc. | Healthcare | 1.20% | $3.4M | $3.17B | — |
| 37 | CORT | Corcept Therapeutics Incorporated | Healthcare | 1.18% | $3.4M | $11.91B | 244.8 |
| 38 | NHC | National HealthCare Corporation | Healthcare | 1.15% | $3.3M | $3.80B | 27.0 |
| 39 | NUVB | Nuvation Bio Inc. | Healthcare | 1.14% | $3.3M | $1.56B | — |
| 40 | QURE | uniQure N.V. | Healthcare | 1.06% | $3.0M | $1.51B | — |
| 41 | ABSI | Absci Corporation | Healthcare | 1.06% | $3.0M | $1.42B | — |
| 42 | PVLA | Palvella Therapeutics, Inc | Healthcare | 1.05% | $3.0M | $1.73B | — |
| 43 | ETON | Eton Pharmaceuticals, Inc. | Healthcare | 1.05% | $3.0M | $1.44B | 125.8 |
| 44 | INBX | Inhibrx, Inc. | Healthcare | 1.00% | $2.9M | $1.32B | — |
| 45 | XNCR | Xencor, Inc. | Healthcare | 0.98% | $2.8M | $1.70B | — |
| 46 | CLOV | Clover Health Investments, Corp. | Healthcare | 0.95% | $2.7M | $2.38B | — |
| 47 | ANRO | Alto Neuroscience, Inc. | Healthcare | 0.94% | $2.7M | $861.0M | — |
| 48 | NEOG | Neogen Corporation | Healthcare | 0.91% | $2.6M | $2.58B | — |
| 49 | GRDN | Guardian Pharmacy Services, Inc. | Healthcare | 0.84% | $2.4M | $2.50B | 38.3 |
| 50 | IMNM | Immunome, Inc. | Healthcare | 0.81% | $2.3M | $1.94B | — |
| 51 | BBNX | Beta Bionics, Inc. | Healthcare | 0.80% | $2.3M | $882.0M | — |
| 52 | CGEM | Cullinan Oncology, Inc. | Healthcare | 0.72% | $2.0M | $794.7M | — |
| 53 | AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional | Other | 0.11% | $316,029.20 | — | — |
Weights as a percentage of net assets. Value held = weight × net assets ($285.5M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
PTH sector breakdown
Sum of the weights of the holdings in each sector.
PTH top industries
PTH overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| IWM | iShares Russell 2000 ETF | 4.3% | 39 of 1,962 | 0.19% |
| VTI | Vanguard Total Stock Market ETF | 0.6% | 51 of 2,941 | 0.03% |
| SPY | SPDR S&P 500 ETF | 0.1% | 2 of 502 | 0.09% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 3 of 8,035 | 0.05% |
| QQQ | Invesco QQQ ETF | 0.0% | 0 of 101 | 0.17% |
| DIA | SPDR Dow Jones Industrial Average ETF | 0.0% | 0 of 30 | 0.16% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the PTH portfolio
Invesco DWA Healthcare Momentum ETF holds 53 positions. The ten largest make up 36.4% of the fund and the top 50 99.1%, so it behaves like a portfolio of about 41 equally weighted stocks. The biggest positions are Iovance Biotherapeutics, Inc. (5.08%), Roivant Sciences Ltd. (3.95%), Natera, Inc. (3.94%), Tenet Healthcare Corporation (3.75%), Guardant Health, Inc. (3.68%).
By sector, Healthcare is 100.6%, Other is 0.1%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: PTH chart, PTH performance, PTH dividends, PTH overview.
PTH holdings FAQ
How many holdings does PTH have?
PTH holds 53 positions as of October 25, 2026.
What are the top 10 holdings of PTH?
The ten largest holdings are Iovance Biotherapeutics, Inc. (5.08%), Roivant Sciences Ltd. (3.95%), Natera, Inc. (3.94%), Tenet Healthcare Corporation (3.75%), Guardant Health, Inc. (3.68%), 10x Genomics, Inc. (3.62%), Revolution Medicines, Inc. (3.50%), Medpace Holdings, Inc. (3.06%), Insmed Incorporated (2.94%), Hinge Health, Inc. (2.90%). Together they are 36.4% of the fund.
What percentage of PTH is Iovance Biotherapeutics, Inc.?
Iovance Biotherapeutics, Inc. is the largest holding at 5.08% of net assets, about $14.5M of the fund's $285.5M.
How concentrated is PTH?
The top 10 holdings are 36.4% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) PTH behaves like a portfolio of about 41 equally weighted stocks.